Park Place Capital Corp Glaukos Corp Transaction History
Park Place Capital Corp
- $319 Million
- Q3 2024
A detailed history of Park Place Capital Corp transactions in Glaukos Corp stock. As of the latest transaction made, Park Place Capital Corp holds 302 shares of GKOS stock, worth $41,808. This represents 0.01% of its overall portfolio holdings.
Number of Shares
302
Previous 302
-0.0%
Holding current value
$41,808
Previous $35,000
11.43%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
340Shares Held
47.1MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.11 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$813 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$302 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$271 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$227 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.59B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...